EGFR and neoplasm: Transcriptional reprogramming and selection of tumor cells with an increased FGF-, IGF-, and PDGF- GF-family member gene expression inducing a signaling bypass to the CET EGFR blockade was identified as likely driver of SR in a subset of SR tumors.